Brittany G Craiglow and Brett A. King, two researchers from Yale University, have documented an extremely successful trial to treat total baldness caused by alopecia with the rheumatoid arthritis drug, tofacitinib citrate. After treatment with the arthritis drug on a 25-year-old patient suffering with both plaque psoriasis and alopecia, researchers reported gradual improvement in the health of the patient and hair growth with no undesirable side effects.
Kyle Rhodes, the patient, was suffering with an autoimmune disease that led to loss of body hair. Dr. George Cotsarelis, chairman of dermatology at the University of Pennsylvania's Perelman School of Medicine, said: "This drug really can have some nasty side effects".